Background/Aims: Impaired renal function is a strong risk factor for cardiovascular diseases and worsens a patient’s prognosis. Renal dysfunction predicts mortality after acute stroke in the long term. On the other hand, in-hospital mortality after acute stroke is strongly associated with disorders of consciousness at the onset of stroke, severity of stroke, body temperature, blood sugar and some other comorbidities. The aim of the study was to analyze the possible role of renal dysfunction and/or signs of renal disease (proteinuria) on 30-day mortality after acute ischaemic stroke (AIS) based on the hospital medical records of one county. Methods: Medical records of 312 consecutive patients admitted to Ostrołęka County Hospital (Department of Neurology) between March 2000 and October 2002 for AIS were retrieved retrospectively to determine factors influencing 30-day survival. None of patients received thrombolytic therapy. Results: Among the patients analyzed, 74 (23.7%) died during the 30-day period. In a simple Cox proportional hazards regression model, negative predictive factors were: older age, higher pulse rate, lower estimated glomerular filtration rate (eGFR), proteinuria, elevated plasma glucose level, diabetes mellitus, atrial fibrillation and chronic heart failure. In a multivariate analysis, independent negative predictors of 30-day morbidity were: age hazard ratio (HR) 1.05 (95% CI 1.02–1.08), eGFR <60 ml/min HR 1.75 (95% CI 1.21–2.19), dipstick proteinuria HR 2.28 (95% CI 1.74–2.82) and plasma glucose level >100 mg/dl HR 2.96 (95% CI 2.22–3.70). Conclusion: The results of this study identify decreased eGFR and presence of dipstick proteinuria as a strong negative predictor of 30-day survival after AIS in patients not treated with thrombolytic agents.

1.
Carter AM, Catto AJ, Mansfield MW, Bamford JM, Grant PJ: Predictive variables for mortality after acute ischemic stroke. Stroke 2007;38:1873–1880.
2.
Stegmayr B, Vinogradova T, Malyutina S, Peltonen M, Nikitin Y, Asplund K: Widening gap of stroke between east and west. Eight-year trends in occurrence and risk factors in Russia and Sweden. Stroke 2000;31:2–8.
3.
Brainin M, Bornstein N, Boysen G, Demarin V: Acute neurological stroke care in Europe: results of the European Stroke Care Inventory. Eur J Neurol 2000;7:5–10.
4.
Menken M, Munsat TL, Toole JF: The global burden of disease study: implications for neurology. Arch Neurol 2000;57:418–420.
5.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB: Probability of stroke: a risk profile from the Framingham Study. Stroke 1991;22:312–318.
6.
Romero JR: Prevention of ischemic stroke: overview of traditional risk factors. Curr Drug Targets 2007;8:794–801.
7.
Roquer J, Ois A, Rodriguez Campello A, Gomis M, Munteis E, Jimenez Conde J, Martinez-Rodriguez JE: Clustering of vascular risk factors and in-hospital death after acute ischemic stroke. J Neurol 2007;254:1636–1641.
8.
Czlonkowska A, Niewada M, Saleh El-Baroni I, Mendel T, Ryglewicz D, Sandercock P, Lewis S: High early case fatality after ischaemic stroke in Poland: exploration of possible explanations in the international stroke trial. J Neurol Sci 2002;202:53–57.
9.
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T: Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006;144:172–180.
10.
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034–2047.
11.
Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Shlipak MG: Kidney dysfunction and fatal cardiovascular disease – an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) Study. Am Heart J 2008;155:62–68.
12.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296–1305.
13.
Koren-Morag N, Goldbourt U, Tanne D: Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006;67:224–228.
14.
MacWalter RS, Wong SY, Wong KY, Stewart G, Fraser CG, Fraser HW, Ersoy Y, Ogston SA, Chen R: Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study. Stroke 2002;33:1630–1635.
15.
Adams HP, Adams RJ, Brott T, Del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ: Guidelines for the early management of patients with ischemic stroke. A scientific statement from the stroke council of the American Stroke Association. Stroke 2003;34:1056–1083.
16.
Gosling P, Czyz J, Nightingale P, Manji M: Microalbuminuria in the intensive care unit: clinical correlates and association with outcomes in 431 patients. Crit Care Med 2006;34:2158–2166.
17.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999;130:461–470.
18.
Adams H, Adams R, Del Zoppo G, Goldstein LB: Guidelines for the early management of patients with ischemic stroke. 2005 guidelines update. A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916–921.
19.
Pawlak K, Naumnik B, Brzosko S, Pawlak D, Mysliwiec M: Oxidative stress – a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol 2004;24:154–161.
20.
Brzosko S, Lebkowska U, Malyszko J, Hryszko T, Krauze-Brzosko K, Mysliwiec M: Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients. Physiol Res 2005;54:597–604.
21.
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137–147.
22.
Covic A, Schiller A, Mardare NG, Petrica L, Petrica M, Mihaescu A, Posta N: The impact of acute kidney injury on short-term survival in an Eastern European population with stroke. Nephrol Dial Transplant 2008;23:2228–2234.
23.
Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP: Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int 2005;67:1112–1119.
24.
O’Hare AM, Bertenthal D, Shlipak MG, Sen S, Chren MM: Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 2005;16:514–519.
25.
Hojs Fabjan T, Hojs R, Tetickovic E, Pecovnik Balon B: Ischaemic stroke – impact of renal dysfunction on in-hospital mortality. Eur J Neurol 2007;14:1351–1356.
26.
Sukhija R, Aronow WS, Kakar P, Garza L, Sachdeva R, Sinha A, Mehta JL: Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol 2006;98:279–281.
27.
Segura J, Campo C, Ruilope LM: Proteinuria: an underappreciated risk factor in cardiovascular disease. Curr Cardiol Rep 2002;4:458–462.
28.
Stehouwer CD, Smulders YM: Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006;17:2106–2111.
29.
Dziedzic T, Slowik A, Szczudlik A: Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6. Clin Chem Lab Med 2004;42:182–185.
30.
Nakase T, Yamazaki T, Ogura N, Suzuki A, Nagata K: The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci 2008;271:104–109.
31.
Beamer NB, Coull BM, Clark WM, Wynn M: Microalbuminuria in ischemic stroke. Arch Neurol 1999;56:699–702.
32.
Andreucci M, Federico S, Andreucci VE: Edema and acute renal failure. Semin Nephrol 2001;21:251–256.
33.
Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B: Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Lond) 1995;88:629–633.
34.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426–2432.
35.
Kes VB, Solter VV, Supanc V, Demarin V: Impact of hyperglycemia on ischemic stroke mortality in diabetic and non-diabetic patients. Ann Saudi Med 2007;27:352–355.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.